Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro

Experimental and Molecular Pathology

Volumn 91, Issue 3, 2011, Pages 733-739

  Bauer, Sabrina ^a   Weiss, Thomas S ^a   Wiest, Reiner ^a   Schacherer, Doris ^a   Hellerbrand, Claus ^a   Farkas, Stefan ^a   Scherer, Marcus N ^a   Ritter, Mirko ^a   Schmitz, Gerd ^a   Schäffler, Andreas ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

CD163; Fatty liver; Monocyte; Portal vein

Indexed keywords

CD163 ANTIGEN; FATTY ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; MESSENGER RNA; OLEIC ACID; PALMITIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRAABDOMINAL FAT; LIPOLYSIS; MACROPHAGE ACTIVATION; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SUBCUTANEOUS FAT; TISSUE LEVEL;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELLS, CULTURED; DOWN-REGULATION; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; UP-REGULATION;

EID: 80053467921     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.07.005     Document Type: Article

References (38)

1. Alvehus M., et al. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010, 18:879-883.
2. Aron-Wisnewsky J., et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J. Clin. Endocrinol. Metab. 2009, 94:4619-4623.
3. Axelsson J., et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am. J. Kidney Dis. 2006, 48:916-925.
4. Ayonrinde O.T., et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011, 53:800-809.
5. Bellido C., et al. Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men. Am. J. Clin. Nutr. 2004, 80:1487-1491.
6. Bouhlel M.A., et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007, 6:137-143.
7. Bouhlel M.A., et al. Peroxisome proliferator-activated receptors-from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease. J. Intern. Med. 2008, 263:28-42.
8. Buechler C., et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 2000, 67:97-103.
9. Davis B.H., Zarev P.V. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin. Cytom. 2005, 63:16-22.
10. de Lima T.M., et al. Fatty acid control of nitric oxide production by macrophages. FEBS Lett. 2006, 580:3287-3295.
11. Etzerodt A., et al. Tumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J. Leukoc. Biol. 2010, 88:1201-1205.
12. Fiorentino L., et al. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 2010, 51:103-110.
13. Fontana L., et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56:1010-1013.
14. Frings W., et al. Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett. 2002, 526:93-96.
15. Hao W., et al. Omega-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J. Pediatr. Surg. 2010, 45:2412-2418.
16. Hintz K.A., et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J. Leukoc. Biol. 2002, 72:711-717.
17. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 2010, 11:11-18.
18. Kopp A., et al. Fatty acids as metabolic mediators in innate immunity. Eur. J. Clin. Invest. 2009, 39:924-933.
19. Lee J.Y., et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276:16683-16689.
20. Martins de Lima T., et al. Comparative toxicity of fatty acids on a macrophage cell line (J774). Clin. Sci. (Lond.) 2006, 111:307-317.
21. Moller H.J., et al. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 2002, 99:378-380.
22. Moller H.J., et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J. Hepatol. 2007, 47:671-676.
23. Moller H.J., et al. Serum soluble CD163 predicts risk of type 2 diabetes in the general population. Clin. Chem. 2011, 57:291-297.
24. Okamoto Y., et al. Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice. Exp. Mol. Pathol. 2007, 83:73-83.
25. Ritter M., et al. The scavenger receptor CD163: regulation, promoter structure and genomic organization. Pathobiology 1999, 67:257-261.
26. Sabio G., et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008, 322:1539-1543.
27. Salm P., et al. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 2011, 25:652-659.
28. Santomauro A.T., et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999, 48:1836-1841.
29. Schaffler A., et al. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005, 2:273-280.
30. Shakeri-Manesch S., et al. Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int. J. Obes. (Lond.) 2009, 33:1257-1264.
31. Sporrer D., et al. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity. Eur. J. Clin. Invest. 2009, 39:671-679.
32. Stogbauer F., et al. Highly efficient and low-cost method to isolate human blood monocytes with high purity. J. Immunol. Methods 2008, 337:78-80.
33. Thasler W.E., et al. Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany. Cell Tissue Bank. 2003, 4:49-56.
34. Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig. Dis. 2010, 28:179-185.
35. Wanninger J., et al. Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. Biochim Biophys Acta. 2011, 1811:626-633.
36. Weaver L.K., et al. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J. Leukoc. Biol. 2007, 81:663-671.
37. Weigert J., et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin. Endocrinol. (Oxf.) 2010, 72:342-348.
38. Wiest R., et al. Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis. Cytokine 2011, 53:178-183.